124 related articles for article (PubMed ID: 30774013)
21. Accuracy of brain perfusion single-photon emission computed tomography for detecting misery perfusion in adult patients with symptomatic ischemic moyamoya disease.
Setta K; Kojima D; Shimada Y; Yoshida J; Oshida S; Fujimoto K; Tsutsui S; Chiba T; Fujiwara S; Terasaki K; Ogasawara K
Ann Nucl Med; 2018 Nov; 32(9):611-619. PubMed ID: 30030783
[TBL] [Abstract][Full Text] [Related]
22. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
[TBL] [Abstract][Full Text] [Related]
23. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
[TBL] [Abstract][Full Text] [Related]
24. Unraveling Specific Brain Microstructural Damage in Moyamoya Disease Using Diffusion Magnetic Resonance Imaging and Positron Emission Tomography.
Hara S; Hori M; Ueda R; Hayashi S; Inaji M; Tanaka Y; Maehara T; Ishii K; Aoki S; Nariai T
J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1113-1125. PubMed ID: 30679013
[TBL] [Abstract][Full Text] [Related]
25. Comparative effectiveness of different antiplatelet agents at reducing TNF-driven inflammatory responses in a mouse model.
Lee HR; Park KY; Jeong YJ; Heo TH
Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):432-438. PubMed ID: 31713877
[TBL] [Abstract][Full Text] [Related]
26. Effect of cilostazol addition or clopidogrel doubling on platelet function profiles in diabetic patients undergoing a percutaneous coronary intervention.
Ha SJ; Kim SJ; Hwang SJ; Woo JS; Kim W; Kim WS; Kim KS; Kim MK
Coron Artery Dis; 2013 Dec; 24(8):690-7. PubMed ID: 24152567
[TBL] [Abstract][Full Text] [Related]
27. Different aspects of dysexecutive syndrome in patients with moyamoya disease and its clinical subtypes.
Fang L; Huang J; Zhang Q; Chan RC; Wang R; Wan W
J Neurosurg; 2016 Aug; 125(2):299-307. PubMed ID: 26722860
[TBL] [Abstract][Full Text] [Related]
28. Antiplatelet Therapy of Cilostazol or Sarpogrelate with Aspirin and Clopidogrel after Percutaneous Coronary Intervention: A Retrospective Cohort Study Using the Korean National Health Insurance Claim Database.
Noh Y; Lee J; Shin S; Lim HS; Bae SK; Oh E; Kim GJ; Kim JH; Lee S
PLoS One; 2016; 11(3):e0150475. PubMed ID: 26939062
[TBL] [Abstract][Full Text] [Related]
29. Antiplatelet Treatment in Moyamoya Disease: A Systematic Review.
Kijpaisalratana N; Ariyaprakai C; Sriamornrattanakul K; Wongsuriyanan S; Akharathammachote N; Susantitaphong P; Suwanwela NC
Cerebrovasc Dis Extra; 2024; 14(1):76-85. PubMed ID: 38697036
[TBL] [Abstract][Full Text] [Related]
30. Cognitive effects of cilostazol in Alzheimer's dementia patients with peripheral arterial occlusive disease: A case-control study.
Chien CF; Huang LC; Li KY; Yang YH
Geriatr Gerontol Int; 2023 Mar; 23(3):194-199. PubMed ID: 36682741
[TBL] [Abstract][Full Text] [Related]
31. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
[TBL] [Abstract][Full Text] [Related]
32. Chronic ischemia alters brain microstructural integrity and cognitive performance in adult moyamoya disease.
Kazumata K; Tha KK; Narita H; Kusumi I; Shichinohe H; Ito M; Nakayama N; Houkin K
Stroke; 2015 Feb; 46(2):354-60. PubMed ID: 25538200
[TBL] [Abstract][Full Text] [Related]
33. Adjunctive loading dose of cilostazol in preventing periprocedural myocardial infarction.
Xu LX; Chen KY; Liu T; Zheng XT; Jiao ZQ; Xu Y; Li G
Cardiovasc Ther; 2016 Aug; 34(4):225-33. PubMed ID: 27133311
[TBL] [Abstract][Full Text] [Related]
34. Effects of Surgery and Antiplatelet Therapy in Ten-Year Follow-Up from the Registry Study of Research Committee on Moyamoya Disease in Japan.
Yamada S; Oki K; Itoh Y; Kuroda S; Houkin K; Tominaga T; Miyamoto S; Hashimoto N; Suzuki N;
J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):340-9. PubMed ID: 26654669
[TBL] [Abstract][Full Text] [Related]
35. Comparison of long-term efficacy and safety between cilostazol and clopidogrel in chronic ischemic stroke: a nationwide cohort study.
Lee TH; Lin YS; Liou CW; Lee JD; Peng TI; Liu CH
Ther Adv Chronic Dis; 2020; 11():2040622320936418. PubMed ID: 32843953
[TBL] [Abstract][Full Text] [Related]
36. Neuropsychological profile associated with Moyamoya disease: A case report.
Indorewalla KK; McArdle M; Tomlinson E; Piryatinsky I
NeuroRehabilitation; 2020; 46(4):603-611. PubMed ID: 31868692
[TBL] [Abstract][Full Text] [Related]
37. Long-term study of the cognitive profile of Moyamoya Disease in adults.
Chan E; Gal AM; Van Harskamp N; Adams ME; Brown MM; Werring DJ; Cipolotti L; Simister R
J Stroke Cerebrovasc Dis; 2023 Jun; 32(6):107064. PubMed ID: 36996746
[TBL] [Abstract][Full Text] [Related]
38. Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: impact of high on-treatment platelet reactivity and diabetes mellitus status.
Capranzano P; Ferreiro JL; Ueno M; Capodanno D; Dharmashankar K; Darlington A; Desai B; Tello-Montoliu A; Rollini F; Angiolillo DJ
Catheter Cardiovasc Interv; 2013 Jan; 81(1):42-9. PubMed ID: 22431415
[TBL] [Abstract][Full Text] [Related]
39. Triple antiplatelet therapy with addition of cilostazol to aspirin and clopidogrel for Y-stent-assisted coil embolization of cerebral aneurysms.
Kono K; Shintani A; Yoshimura R; Okada H; Tanaka Y; Fujimoto T; Tomura N; Terada T
Acta Neurochir (Wien); 2013 Aug; 155(8):1549-57. PubMed ID: 23715948
[TBL] [Abstract][Full Text] [Related]
40. Correlation between cognitive impairment and cerebral hemodynamic disturbances on perfusion magnetic resonance imaging in European adults with moyamoya disease. Clinical article.
Calviere L; Catalaa I; Marlats F; Viguier A; Bonneville F; Cognard C; Larrue V
J Neurosurg; 2010 Oct; 113(4):753-9. PubMed ID: 20469988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
